Study of Doxil in the Treatment of Patients With Refractory Idiopathic Thrombocytopenic Purpura
NCT00107913
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Autoimmune Thrombocytopenic Purpura
Interventions
DRUG:
Doxil
Sponsor
Hematology and Oncology Specialists